- Tumor stages and histopathology subtypes, treatment modality, recurrence rate and patient status (N=40).
| Variables | n (%) |
|---|---|
| Histopathology subtype | |
| Germ cell tumor | 18 (45.0) |
| Sex cord-stromal | 18 (45.0) |
| Sarcoma | 4 (10.0) |
| Histopathology subtype | |
| Germ cell tumor | 18 (45.0) |
| Sex cord-stromal | 18 (45.0) |
| Sarcoma | 4 (10.0) |
| Tumor stage (early/late) | |
| Early (FIGO stage 2B and below) | 22 (55.0) |
| Late (FIGO stage 3A and later) | 14 (35.0) |
| Unknown | 4 (10.0) |
| Surgical procedure | |
| Biopsy | |
| Yes | 40 (100.0) |
| No | 0 |
| Suboptimal cytoreductive surgery | |
| Yes | 12 (30.0) |
| No | 17 (42.5.0) |
| Unknown | 11 (27.5.0) |
| Optimal cytoreductive surgery | |
| Yes | 17 (42.5) |
| No | 12 (30) |
| Unknown | 11(27.5) |
| Other surgeries | |
| Yes | 9 (17.5) |
| No | 31 (82.5) |
| Chemotherapy# of chemotherapy | |
| No chemotherapy | 11 (27.5) |
| 1 line chemotherapy | 20 (50.0) |
| >1 line chemotherapy | 9 (22.5) |
| Recurrence | |
| Yes | 13 (32.5) |
| No | 20 (50.0) |
| Unknown | 7 (17.5) |
| Patient status | |
| On remission | 21 (52.5) |
| Still on treatment | 5 (12.5) |
| Died of cancer | 6 (15.0) |
| Unknown | 8 (20.0) |